| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 03/15/2007 | WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | US20070060757 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms |
| 03/15/2007 | US20070060624 Novel bioisosteres of actinonin |
| 03/15/2007 | US20070060606 Compounds and methods for modulating phosphodiesterase 10A |
| 03/15/2007 | US20070060568 5HT2c receptor modulators |
| 03/15/2007 | CA2621836A1 Isoquinolines as igf-1r inhibitors |
| 03/15/2007 | CA2621448A1 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/14/2007 | EP1761545A2 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 03/14/2007 | EP1761522A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761515A1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives |
| 03/14/2007 | EP1163240B1 Tricyclic benzoylpyrazole derivatives used as a herbicide |
| 03/14/2007 | EP1045837B1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof |
| 03/14/2007 | CN1930171A 7H-8,9-dihydro-pyrano(2,3-C)imidazo(1,2A)pyridine derivatives and their use as gastric acid secretion inhibitors |
| 03/14/2007 | CN1930145A Cycloalkanopyridine derivative |
| 03/14/2007 | CN1927840A Aromatic reductive derivative of geldanamycin benzoquinone, preparation method and use thereof |
| 03/14/2007 | CN1304395C New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189851 Condensed heterocyclic compounds as calcitonin agonists |
| 03/13/2007 | US7189736 Prodrugs of imidazopyridine derivatives |
| 03/13/2007 | US7189734 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
| 03/13/2007 | US7189549 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthase and accessory proteins, and uses thereof |
| 03/13/2007 | CA2112866C Novel derivatives of 2-cyano-3-hydroxy-propenamides, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them |
| 03/08/2007 | WO2007027959A1 Novel benzopyran derivatives as potassium channel openers |
| 03/08/2007 | WO2006124490A3 Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia |
| 03/08/2007 | US20070054939 N-ethyl-N-(1-methyl-2-oxo-2-phenylethyl)2-[1(4'-trifluoromethylbiphenyl-2-carbonyl)piperid-4-yl]thiazole-4-carbamate ; hypertriglyceridaemia, hypercholesterolaemia, or dyslipidaemia associated with diabetes; microsomal triglyceride transfer protein (MTP), |
| 03/08/2007 | US20070054935 Novel pyridine derivatives as potassium ion channel openers |
| 03/08/2007 | US20070054934 Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent |
| 03/08/2007 | US20070054929 2-Substituted pyrimidines |
| 03/08/2007 | US20070054909 VLA-4 inhibitor compounds |
| 03/08/2007 | CA2620894A1 Novel benzopyran derivatives as potassium channel openers |
| 03/08/2007 | CA2620864A1 Raf inhibitor compounds and methods of use thereof |
| 03/08/2007 | CA2620846A1 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 03/07/2007 | EP1758909A1 Furanopyrimidine compounds effective as potassium channel inhibitors |
| 03/07/2007 | EP1758908A1 Extraction of alkaloids from opium |
| 03/07/2007 | EP1758907A1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
| 03/07/2007 | EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/07/2007 | EP1758882A1 Amido compounds and their use as pharmaceuticals |
| 03/07/2007 | EP1758873A1 Ubiquitin ligase inhibitors |
| 03/07/2007 | EP1758453A2 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 03/07/2007 | EP1440066B1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 03/07/2007 | EP1427728B1 6,7-DIHYDRO-5H-PYRAZOLO 1,2-A PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY cYTOKINES |
| 03/07/2007 | EP1362052B1 Inhibitors of cruzipain and other cysteine proteases |
| 03/07/2007 | EP1303519B1 Tricyclic imidazopyridines |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | CN1926129A Novel insecticides |
| 03/07/2007 | CN1926117A 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power |
| 03/07/2007 | CN1926107A Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions |
| 03/07/2007 | CN1925859A 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy |
| 03/07/2007 | CN1923832A Novel pyridazinone compound, preparation method and application thereof |
| 03/07/2007 | CN1923820A Novel carboxylic acid derivatives, their preparation and use |
| 03/07/2007 | CN1923813A Aporphine and use of oxidized aporphine alkaloid |
| 03/07/2007 | CN1303084C New cephalotaxanes, their method of preapartion and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapentic agents and reversal agents |
| 03/06/2007 | US7186847 Process for the direct preparation of pyrrolo[3,4-c]pyrroles |
| 03/06/2007 | US7186836 Thienyl compounds |
| 03/06/2007 | US7186832 anticancer agents; antidiabetic agents; autoimmune disease; restenosis; antiarthritic agents; skin disorders; cardiovascular disorders; antiinflammatory agents |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/01/2007 | WO2007023507A2 Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| 03/01/2007 | WO2007002181A3 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 03/01/2007 | WO2006014325A3 C-met modulators and method of use |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | WO2005030711A3 Bridged macrocyclic module compositions |
| 03/01/2007 | US20070049603 Raf inhibitor compounds and methods of use thereof |
| 03/01/2007 | US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine |
| 03/01/2007 | US20070049566 Methods and Compositions for inhibition of angiogenesis |
| 03/01/2007 | CA2620052A1 Indenoisoquinolinone analogs and methods of use thereof |
| 03/01/2007 | CA2618087A1 Bridged n-bicyclic sulfonamido inhibitors of gamma secretase |
| 02/28/2007 | EP1757609A1 Novel water-soluble prodrug |
| 02/28/2007 | EP1757608A1 New benzazepine derivatives, medicaments containing the same and their use in the preparation of medicaments |
| 02/28/2007 | EP1757605A1 Cyclic amine compound |
| 02/28/2007 | EP1757599A1 Indole derivatives having piperidine rings |
| 02/28/2007 | EP1756069A2 Hiv integrase inhibitors |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1425286B1 Substituted 7-aza-[2.2.1]bicycloheptanes for the treatment of diseases |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | CN1922189A Spirocyclic cyclohexane derivatives with affinity for the ORL1-receptor |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922169A Spirocyclic heterocyclic derivatives and methods of their use |
| 02/28/2007 | CN1922166A Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives |
| 02/28/2007 | CN1922149A Pyrrole and pyrazole daao inhibitors |
| 02/28/2007 | CN1922141A Novel heterocyclic compound |
| 02/28/2007 | CN1922135A 免疫抑制剂化合物和组合物 Immunosuppressant compounds and compositions |
| 02/28/2007 | CN1921854A Heterocyclic GABAA subtype selective receptor modulators |
| 02/28/2007 | CN1921853A Preventive or therapeutic agents for severe diabetic retinopathy |
| 02/28/2007 | CN1302002C Hydroxylamine esters as polymerization initiators |
| 02/28/2007 | CN1301996C Novel anticancer conjugates of camptothecin and unsaturated fatty acids |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183417 Which has antitumor activity; starting from (2S, 3R)-methyl 2-(4-methoxybenzamido)-3-hydroxybutanoate and cyclizing to Methyl 4,5-dihydro-2 (4-methoxyphenyl)-5-methyloxazole-4-carboxylate |
| 02/27/2007 | US7183405 Labeling oligonucleotides comprising providing a solid support-bound oligonucleotide, an amino group comprised of bifunctional linker arm and an activated label, react support-bound oligonucleotide with bifunctional linker arm, react support with label, recover labeled, support-bound protected oligomer |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183313 Keto cannabinoids with therapeutic indications |
| 02/27/2007 | US7183282 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 02/27/2007 | US7182953 Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
| 02/22/2007 | WO2007022102A2 Pentacyclic kinase inhibitors |
| 02/22/2007 | WO2007021897A1 Analogs of salinosporamide a |
| 02/22/2007 | WO2007021674A2 Method of acylating maytansinol with chiral amino acids |
| 02/22/2007 | WO2007019674A1 Viral polymerase inhibitors |